The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase

It is well documented that disturbances in mitochondrial function are associated with rare childhood disorders and possibly with many common diseases of ageing, such as Parkinson's disease and dementia. There has also been increasing evidence linking mitochondrial dysfunction with tumorigenesis. Recently, heterozygous germline mutations in two enzymes of the Krebs tricarboxylic acid cycle (TCA cycle) have been shown to predispose individuals to tumours. The two enzymes, fumarate hydratase (FH) and succinate dehydrogenase (SDH), are ubiquitously expressed, playing a vital role in adenosine triphosphate (ATP) production through the mitochondrial respiratory chain. Germline mutations in FHare associated with leiomyomatosis and renal cell carcinoma, whilst SDHmutations are associated with predisposition to paraganglioma (PGL) and phaeochromocytoma (PCC). At present, there are few data to explain the pathway(s) involved in this predisposition to neoplasia through TCA cycle defects. We shall review the mechanisms by which mutations in FHand SDHmight play a role in tumorigenesis. These include pseudo‐hypoxia, mitochondrial dysfunction and impaired apoptosis, oxidative stress and anabolic drive. All of these mechanisms are currently poorly defined. To date, FHand SDHmutations have not been reported in non‐familial leiomyomata, renal cancers, PCCs or PGLs. It remains entirely possible, however, that the underlying mechanisms of tumorigenesis in these sporadic tumours are the same as those in the Mendelian syndromes.

[1]  A. Paetau,et al.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.

[2]  A. Munnich,et al.  Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. , 2000 .

[3]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[4]  K. Yasuda,et al.  A Defect in the Cytochrome b Large Subunit in Complex II Causes Both Superoxide Anion Overproduction and Abnormal Energy Metabolism in Caenorhabditis elegans * , 2001, The Journal of Biological Chemistry.

[5]  J. Crow,et al.  Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium. , 2001, Clinical science.

[6]  S. Iwata,et al.  Architecture of Succinate Dehydrogenase and Reactive Oxygen Species Generation , 2003, Science.

[7]  S. Beeckmans,et al.  Pig Heart Fumarase Contains Two Distinct Substrate-binding Sites Differing in Affinity* , 1998, The Journal of Biological Chemistry.

[8]  S. Mane,et al.  Insights from gene arrays on the development and growth regulation of uterine leiomyomata. , 2002, Fertility and sterility.

[9]  E S Husebye,et al.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.

[10]  W. Rubinstein,et al.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas , 2002, Journal of medical genetics.

[11]  Kuender D Yang,et al.  Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels. , 2002, Clinical immunology.

[12]  P. Rustin,et al.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.

[13]  J. Matés,et al.  Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. , 2002, The international journal of biochemistry & cell biology.

[14]  D. Spitz,et al.  Glucose Deprivation-induced Cytotoxicity and Alterations in Mitogen-activated Protein Kinase Activation Are Mediated by Oxidative Stress in Multidrug-resistant Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[15]  R. Houlston,et al.  Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. , 2001, American journal of human genetics.

[16]  C. Bruno,et al.  Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA , 1998, Neurology.

[17]  M. Zeviani,et al.  Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes , 1990, Neurology.

[18]  Eamonn R. Maher,et al.  Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* , 2000, The Journal of Biological Chemistry.

[19]  D. Leigh.  SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANT , 1951, Journal of neurology, neurosurgery, and psychiatry.

[20]  P H Watson,et al.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases. , 2000, Cancer research.

[21]  K. Savolainen,et al.  Amplification of glutamate-induced oxidative stress. , 1995, Toxicology Letters.

[22]  Ulrich Müller,et al.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.

[23]  G. Dallner,et al.  Biochemical, physiological and medical aspects of ubiquinone function. , 1995, Biochimica et biophysica acta.

[24]  D. Levitt,et al.  Purification and crystallization of fumarase C from Escherichia coli. , 1993, Journal of molecular biology.

[25]  T. Bourgeron,et al.  Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. , 1997, Biochimica et biophysica acta.

[26]  D. Levitt,et al.  The multisubunit active site of fumarase C from Escherichia coli , 1995, Nature Structural Biology.

[27]  J. Schipper,et al.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[28]  B. Delahunt,et al.  Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. , 2002, Cancer research.

[29]  M. Ivan,et al.  von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. , 2001, Human molecular genetics.

[30]  G. Kovacs,et al.  Alteration of mitochondrial DNA in human oncocytomas , 1989, Genes, chromosomes & cancer.

[31]  P. Ratcliffe,et al.  Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. , 2001, Human molecular genetics.

[32]  Charis Eng,et al.  A role for mitochondrial enzymes in inherited neoplasia and beyond , 2003, Nature Reviews Cancer.

[33]  A. Munnich,et al.  Succinate dehydrogenase and human diseases: new insights into a well-known enzyme , 2002, European Journal of Human Genetics.

[34]  Jessica Lo,et al.  HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .

[35]  H. Ryan,et al.  HIF-1 alpha is required for solid tumor formation and embryonic vascularization. , 1998, The EMBO journal.

[36]  N P Burrows,et al.  Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. , 2003, Human molecular genetics.

[37]  A. Munnich,et al.  Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome , 2000, Human Genetics.

[38]  M. Vikkula,et al.  A novel mutation in the SDHD gene in a family with inherited paragangliomas—implications of genetic diagnosis for follow up and treatment , 2003, Head & neck.

[39]  U. Müller,et al.  Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC , 2003, Human Genetics.

[40]  P. Rustin,et al.  Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. , 2002, The Journal of clinical endocrinology and metabolism.

[41]  K. Mielke,et al.  Caspase-3 activation and DNA fragmentation in primary hippocampal neurons following glutamate excitotoxicity. , 2001, Brain research. Molecular brain research.

[42]  R. Houlston,et al.  Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas , 2002, British Journal of Cancer.

[43]  L. Aaltonen,et al.  Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. , 2001, The American journal of pathology.

[44]  L. Aaltonen,et al.  Inherited susceptibility to uterine leiomyomas and renal cell cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  L. Banaszak,et al.  Crystallographic studies of the catalytic and a second site in fumarase C from Escherichia coli. , 1996, Biochemistry.

[46]  D. Marsh,et al.  Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas , 2003, Oncogene.

[47]  W. Zong,et al.  Bcl-2 Family Members and Functional Electron Transport Chain Regulate Oxygen Deprivation-Induced Cell Death , 2002, Molecular and Cellular Biology.

[48]  Thomas Bourgeron,et al.  Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency , 1995, Nature Genetics.

[49]  A. Munnich,et al.  Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. , 1994, The Journal of clinical investigation.